- Home
- EVAX vs KAPA Comparison
EVAX vs KAPA Comparison
Compare EVAX & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- KAPA
- Stock Information
- Founded
- EVAX 2008
- KAPA 2013
- Country
- EVAX Denmark
- KAPA United States
- Employees
- EVAX N/A
- KAPA N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- KAPA
- Sector
- EVAX Health Care
- KAPA
- Exchange
- EVAX Nasdaq
- KAPA NYSE
- Market Cap
- EVAX 10.8M
- KAPA 9.1M
- IPO Year
- EVAX 2021
- KAPA 2024
- Fundamental
- Price
- EVAX $2.54
- KAPA $0.66
- Analyst Decision
- EVAX Strong Buy
- KAPA Strong Buy
- Analyst Count
- EVAX 2
- KAPA 3
- Target Price
- EVAX $10.00
- KAPA $8.33
- AVG Volume (30 Days)
- EVAX 125.9K
- KAPA 2.2M
- Earning Date
- EVAX 08-13-2025
- KAPA 08-23-2025
- Dividend Yield
- EVAX N/A
- KAPA N/A
- EPS Growth
- EVAX N/A
- KAPA N/A
- EPS
- EVAX N/A
- KAPA N/A
- Revenue
- EVAX $3,293,000.00
- KAPA N/A
- Revenue This Year
- EVAX N/A
- KAPA N/A
- Revenue Next Year
- EVAX N/A
- KAPA N/A
- P/E Ratio
- EVAX N/A
- KAPA N/A
- Revenue Growth
- EVAX 2555.64
- KAPA N/A
- 52 Week Low
- EVAX $1.20
- KAPA $0.40
- 52 Week High
- EVAX $17.75
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- EVAX 55.40
- KAPA N/A
- Support Level
- EVAX $2.07
- KAPA N/A
- Resistance Level
- EVAX $2.95
- KAPA N/A
- Average True Range (ATR)
- EVAX 0.30
- KAPA 0.00
- MACD
- EVAX -0.05
- KAPA 0.00
- Stochastic Oscillator
- EVAX 45.86
- KAPA 0.00
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.